U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 16

1.
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment
Christopher H. Goss, Sonya L. Heltshe, Natalie E. West, Michelle Skalland, Don B. Sanders, Raksha Jain, Tara L. Barto, Barbra Fogarty, Bruce C. Marshall, Donald R. VanDevanter, Patrick A. Flume, on behalf of the STOP2 Investigators
Am J Respir Crit Care Med. 2021 Dec 1; 204(11): 1295–1305. Published online 2021 Mar 30. doi: 10.1164/rccm.202102-0461OC
PMCID:
PMC8786075
ArticlePubReaderPDF–722KCite
2.
Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
Maryam Hassanzad, Arda Kiani, Atefeh Abedini, Hoseinali Ghaffaripour, Habib Emami, Niloufar Alizadeh, Ghazal Zoghi, Saeed Hashemi, Ali Akbar Velayati
BMC Pulm Med. 2021; 21: 353. Published online 2021 Nov 8. doi: 10.1186/s12890-021-01728-8
PMCID:
PMC8572653
ArticlePubReaderPDF–829KCite
3.
Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment
DR VanDevanter, SL Heltshe, DB Sanders, NE West, M Skalland, PA Flume, CH Goss
J Cyst Fibros. Author manuscript; available in PMC 2022 Jan 1.
Published in final edited form as: J Cyst Fibros. 2021 Jan; 20(1): 36–38. Published online 2020 Aug 13. doi: 10.1016/j.jcf.2020.08.006
PMCID:
PMC8298137
ArticlePubReaderPDF–465KCite
4.
Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment
Jonathan D. Cogen, Anna V. Faino, Frankline Onchiri, Ronald L. Gibson, Lucas R. Hoffman, Matthew P. Kronman, Margaret Rosenfeld, David P. Nichols
Ann Am Thorac Soc. 2021 Feb; 18(2): 266–272. doi: 10.1513/AnnalsATS.202002-176OC
PMCID:
PMC7869777
ArticlePubReaderPDF–627KCite
5.
Multivariate joint modeling to identify markers of growth and lung function decline that predict cystic fibrosis pulmonary exacerbation onset
E. R. Andrinopoulou, J. P. Clancy, R. D. Szczesniak
BMC Pulm Med. 2020; 20: 142. Published online 2020 May 19. doi: 10.1186/s12890-020-1177-z
PMCID:
PMC7236487
ArticlePubReaderPDF–1.4MCite
6.
Metabolomics Analysis Identifies Novel Plasma Biomarkers of Cystic Fibrosis Pulmonary Exacerbation
Theresa A. Laguna, Cavan S. Reilly, Cynthia B. Williams, Cole Welchlin, Chris H. Wendt
Pediatr Pulmonol. Author manuscript; available in PMC 2017 Aug 11.
Published in final edited form as: Pediatr Pulmonol. 2015 Sep; 50(9): 869–877. Published online 2015 Jun 26. doi: 10.1002/ppul.23225
PMCID:
PMC5553866
ArticlePubReaderPDF–447KCite
7.
Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
Don B. Sanders, Rachel C. L. Bittner, Margaret Rosenfeld, Lucas R. Hoffman, Gregory J. Redding, Christopher H. Goss
Am J Respir Crit Care Med. 2010 Sep 1; 182(5): 627–632. doi: 10.1164/rccm.200909-1421OC
PMCID:
PMC5450763
ArticlePubReaderPDF–781KCite
8.
Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response
John C Lam, Ranjani Somayaji, Michael G Surette, Harvey R Rabin, Michael D Parkins
BMC Infect Dis. 2015; 15: 145. Published online 2015 Mar 22. doi: 10.1186/s12879-015-0856-5
PMCID:
PMC4392784
ArticlePubReaderPDF–1.1MCite
9.
Oral Antimicrobial Use in Outpatient Cystic Fibrosis Pulmonary Exacerbation Management; a Single Center Experience
Elissa C. Briggs, Thuan Nguyen, Michael C. Wall, Kelvin D. MacDonald
Clin Respir J. Author manuscript; available in PMC 2014 Feb 25.
Published in final edited form as: Clin Respir J. 2012 Jan; 6(1): 56–64. Published online 2011 Aug 9. doi: 10.1111/j.1752-699X.2011.00246.x
PMCID:
PMC3934104
ArticlePubReaderPDF–473KCite
10.
Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial
Ruth E. Grossmann, Susu M. Zughaier, Meena Kumari, Shabnam Seydafkan, Robert H. Lyles, Shuling Liu, Viranuj Sueblinvong, Michael S. Schechter, Arlene A. Stecenko, Thomas R. Ziegler, Vin Tangpricha
Dermatoendocrinol. 2012 Apr 1; 4(2): 191–197. doi: 10.4161/derm.20332
PMCID:
PMC3427199
ArticlePubReaderPDF–683KCite
11.
Iron Homeostasis during Cystic Fibrosis Pulmonary Exacerbation
Alex H. Gifford, Lisa A. Moulton, Dana B. Dorman, Gordana Olbina, Mark Westerman, H. Worth Parker, Bruce A. Stanton, George A. O’Toole
Clin Transl Sci. 2012 Aug; 5(4): 368–373. Published online 2012 Jun 1. doi: 10.1111/j.1752-8062.2012.00417.x
PMCID:
PMC3419499
ArticlePubReaderPDF–1.2MCite
12.
Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset
Geraint B Rogers, Lucas R Hoffman, Matt W Johnson, Nicole Mayer-Hamblett, Jürgen Schwarze, Mary P Carroll, Kenneth D Bruce
Expert Rev Mol Diagn. Author manuscript; available in PMC 2011 Aug 2.
Published in final edited form as: Expert Rev Mol Diagn. 2011 Mar; 11(2): 197–206. doi: 10.1586/erm.10.117
PMCID:
PMC3148893
ArticlePubReaderPDF–125KCite
13.
Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis
Lisa A. Carmody, Linda M. Kalikin, Donald R. VanDevanter, Gen Li, Kristopher Opron, Richard H. Simon, Lindsay J. Caverly, John J. LiPuma
J Cyst Fibros. Author manuscript; available in PMC 2023 Sep 1.
Published in final edited form as: J Cyst Fibros. 2022 Sep; 21(5): 766–768. Published online 2022 Jun 4. doi: 10.1016/j.jcf.2022.05.011
PMCID:
PMC10440828
ArticlePubReaderPDF–575KCite
14.
Approaches for Genetic Discoveries in the Skin Commensal and Pathogenic Malassezia Yeasts
Giuseppe Ianiri, Joseph Heitman
Front Cell Infect Microbiol. 2020; 10: 393. Published online 2020 Aug 7. doi: 10.3389/fcimb.2020.00393
PMCID:
PMC7426719
ArticlePubReaderPDF–2.1MCite
15.
Testing the neutral theory of biodiversity with the microbiome dataset from cystic fibrosis patients
Qi Huang, Yaqiang Wang, Yao Xia, Lianwei Li, Juan Luo, Shuxian Xia, Yang Sun, Yinglei Miao, Kunhua Wang, Ye Chen
Medicine (Baltimore) 2018 Sep; 97(37): e12248. Published online 2018 Sep 14. doi: 10.1097/MD.0000000000012248
PMCID:
PMC6156045
ArticlePubReaderPDF–309KCite
16.
Nitric oxide metabolites in cystic fibrosis lung disease
H Grasemann, I Ioannidis, R Tomkiewicz, H de Groot, B Rubin, F Ratjen
Arch Dis Child. 1998 Jan; 78(1): 49–53. doi: 10.1136/adc.78.1.49
PMCID:
PMC1717443
SummaryPDF–131KCite

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center